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Impact of Early and Delayed Postoperative Myocardial Infarction on
Late Survival in Patients Undergoing Vascular Surgery
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Objectives: Perioperative myocardial infarction (MI) has been shown
to increase early and late mortality after vascular surgical (VS) procedures.
We evaluated the frequency and timing of MI after VS and its impact on sur-
vival across a heterogeneous cohort of VS patients.
Methods: All patients undergoing a spectrum of VS (open aortic
resection, endovascular aneurysm repair/thoracic endovascular aortic repair,
carotid endarterectomy/carotid angioplasty and stenting, or lower extrem-
ity bypass) from July 2007 to May 2012 were included. MI was diagnosed
by electrocardiogram changes, elevated troponin, or diagnosis by a cardiol-
ogist. Patients were identiﬁed by Current Procedural Terminology code us-
ing an institutional patient data research registry consisting of
administrative/clinical data and stratiﬁed according to the temporal rela-
tionship of the MI to the indexed procedure (early: #30 days; intermediate:
1 month to 1 year; late: >1 year). Univariate and multivariate methods were
used to identify predictors of MI and its impact on survival.
Results: We identiﬁed 2984 patients who underwent VS during the
study interval. Early MI was observed in 110 (3.7%), intermediate MI in
66 (2.2%), and late MI in 136 (4.5%). Patient age per year (odds ratio
[OR], 1.02; 95% conﬁdence interval [CI], 1.0002-1.05; P¼ .03) and history
of coronary artery disease (CAD; OR, 4.6; 95% CI, 2.8-7.5; P < .01) inde-
pendently predicted risk of early MI. Intermediate MI was predicted by his-
tory of CAD (OR, 3.2; 95% CI, 1.9-5.3; P< .01) and diabetes (OR, 1.7; 95%
CI, 1.1-2.7; P ¼ .02). Procedure type was not predictive of perioperative or
delayed MI. Patients who had an MI within the ﬁrst year had a lower (log-
rank P < .001) survival at 1 year (77% 6 3% vs 92% 6 1%) and 5 years
(61% 6 5% vs 71% 6 2%; Fig). Risk-adjusted (age, gender, CAD, race, hy-
pertension) Cox regression modeling showed that early MI (HR, 1.5; 95%
CI, 1.01-2.2; P ¼ .04) and, more importantly, intermediate MI (HR, 2.2;
95% CI, 1.5-3.2; P< .01) independently predicted increase in late mortality,
whereas late MI had no impact (HR, 1.03; 95% CI, 0.7-1.6; P ¼ .9).
Conclusions: The incidence of MI within the ﬁrst year after major
vascular procedures remains low yet is predicted by a history of CAD and
diabetes. Readily identiﬁable high-risk patients should have focused inten-
sive medical therapy before and after VS.
Fig. Late survival in vascular surgery patients stratiﬁed by MI.
Outcomes of Reoperative Open or Endovascular Interventions to
Treat Patients With Failing Open Mesenteric Reconstructions for
Mesenteric Ischemia
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Thomas C. Bower, MD1. 1Mayo Clinic, Rochester, Minn; 2Cleveland
Clinic, Cleveland, OhioObjectives: Outcomes of reinterventions for failing open mesenteric
reconstructions (ORs) have not been described. Reoperative ORs
(R-ORs) can be challenging because of excessive scar and more advanced
mesenteric disease. The purpose of this study was to evaluate outcomes of
R-ORs and endovascular revascularizations (ERs) in patients with stenosis
or occlusion of ORs.
Methods: We reviewed a cohort of 593 patients treated for chronic
mesenteric ischemia (CMI) in two academic centers from 1991 to 2013.
Clinical data and outcomes of patients treated for failing ORs with R-ORs
or ERs were included in the analysis. Case-control propensity score match-
ing was used to analyze outcomes of R-ORs compared with patients who
underwent their ﬁrst-time ORs for CMI. End points were early and late
mortality, morbidity, patency rates, and freedom from symptom recurrence
and reintervention.
Results: There were 47 patients (5 male, 42 female; mean age, 58 6
13 years) treated by reinterventions for failing ORs. Clinical presentation
was CMI in 38 patients (81%) or acute mesenteric ischemia (AMI) in
nine (19%). Reinterventions included R-ORs in 28 patients (19 CMI and
9 AMI) and ERs in 19, all for CMI. Early mortality was 22% in patients
treated by R-ORs for AMI. There were no early deaths among patients
treated for CMI with R-OR or ER. Early morbidity was 78% for R-ORs
in patients treated for AMI. Morbidity was signiﬁcantly higher for R-ORs
than for ERs in patients with CMI (68% vs 16%; P < .001). Mean
follow-up was 50 6 60 months. Patient survival at 5 years was 60% 6 8%
for the entire cohort. Primary and secondary patency at 1 year was 61% 6
10% and 92% 6 8% for R-ORs and 77% 6 10% and 100% for ERs, respec-
tively, (P ¼ not signiﬁcant). Freedom from symptom recurrence and reinter-
ventions at 1 year was 88% 6 6% and 87% 6 7% for R-ORs and 83% 6 8%
and 71% 6 10% for ERs. Using propensity score matched comparison,
R-ORs were associated with similar mortality, morbidity, patency, recur-
rence, and reintervention rates compared with ﬁrst-time ORs.
Conclusions: Reinterventions for failing open mesenteric reconstruc-
tions using R-OR or ER interventions carry similar mortality, patency, recur-
rence, and reintervention rates. Early morbidity is signiﬁcantly lower with
endovascular compared with R-ORs performed for CMI. Outcomes of R-
ORs are similar to those obtainedwith the ﬁrst timeORs in patientswithCMI.
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Objectives: Retrograde open mesenteric stenting (ROMS) via lapa-
rotomy was introduced as an alternative to surgical bypass in patients with
acute mesenteric ischemia (AMI). The purpose of this study was to evaluate
the indications and outcomes of ROMS for treatment of acute and chronic
mesenteric ischemia (CMI).
Methods: We reviewed the clinical data and outcomes of all consecu-
tive patients treated by ROMS in seven academic centers from 2001 to
2013. ROMS was performed via laparotomy with retrograde access into
the target mesenteric artery and stent placement using a retrograde or ante-
grade approach, or both. End points were early and late (>30 days) mortal-
ity, morbidity, patient survival, patency rates, and freedom from symptom
recurrence and reintervention.
Results: There were 54 patients, 13 male and 41 female, with mean
age of 71 6 11 years. Indications for ROMS were AMI in 44 patients
(81%) and CMI with ﬂush mesenteric occlusions in 10 (19%). Four celiac
axis lesions and 53 superior mesenteric artery lesions were treated by stent-
ing. The mean stent length was 42 6 25 mm. Retrograde mesenteric access
was used in all patients, but 16 required a simultaneous antegrade approach.
The retrograde puncture was closed primarily in 35 patients or with patch
angioplasty in 17 and manual compression in one. Bowel resection was
needed in 29 patients (54%) with AMI because of perforation or gangrene.
Technical success was 98%. One patient was treated by bypass because an
attempted ROMS failed. Early mortality was 41% (18 of 44) for AMI and
10% (1 of 10) for CMI (P < .01). Early morbidity was 73% for AMI and
50% for CMI (P < .01). Mean follow-up was 11 6 19 months. Patient sur-
vival at 1 year was 36% 6 11% for AMI and 68% 6 12% for CMI (P ¼ .29).
For the entire cohort, primary and secondary patency was 65% 6 11% and
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tions was 75% 6 10% and 71% 6 10% at the same interval.
Conclusions: ROMS offers an alternative to bypass and percutaneous
stenting in patients with AMI who require abdominal exploration for sus-
pected bowel gangrene and for those with ﬂush mesenteric occlusions
who are not ideal candidates for percutaneous stenting. The technique
can be performed with high technical success. Mortality remains high in pa-
tients with AMI. Morbidity is high for patients with AMI and CMI. Patency
rates and freedom from symptom recurrence and reinterventions are compa-
rable to results of stenting using percutaneous technique.
Standardization of a Multidisciplinary Clinical Pathway Improves
Outcomes in Ruptured Abdominal Aortic Aneurysms
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Objectives: Although standardized protocols have been shown to
improve safety in aviation and multidisciplinary care improves outcomes in
oncologic surgery, a standardized multidisciplinary pathway for the treat-
ment of ruptured abdominal aortic aneurysms (rAAAs) has not yet been
described. We aim to describe and evaluate a standardized clinical pathway
for the care of rAAAs.
Methods: Since 2002, our institution has managed an average of 30
rAAAs per year. In 2007, we developed and initiated a multidisciplinary clin-
ical pathway to aid in expediting the care of patients with a rAAA from initial
presentation at the referring facility to deﬁnitive care. This pathway includes
electronic publication of prehospital care protocols for referring providers as
well as a streamlined system for electronic transfer of imaging and records
from other institutions. We have initiated protocols for prehospital and
transfer providers, including guidelines for permissive hypotension as well
as emergent patient registration and emergency department bypass and
transfer directly to the operating room once the patient arrives at our insti-
tution. Circulating and scrub nurse protocols for education and operating
room preparation are in place as well as anesthetic guidelines, including
delay of induction until proximal aortic control is achieved. Finally, the
endovascular rAAA repair (EVAR) procedure and postoperative transfer
of care is outlined in detail to achieve optimal patient outcomes.
Results: Before initiation of the multidisciplinary pathway, 131 pa-
tients with a rAAA presented between 2002 and 2007, and 128 of these pa-
tients were treated with open surgical repair, with 30-day mortality rate of
57.8%. After initiation of our multidisciplinary clinical pathway, 118 patients
presented with a rAAA between July 2007 and February 2012. One hun-
dred were treated surgically, and 72 survived to discharge, with an overall
30-day mortality of 28%. Subset analysis revealed 21 of 39 patients treated
with open surgery survived, with 30-day mortality of 46%, and 51 of 61 pa-
tients treated with EVAR survived, with 30-day mortality of 16%.
Conclusions: rAAA remains a clinical challenge despite advances in
preoperative, intraoperative, and postoperative care. Although adherence to
protocols across multiple sites and specialties can be difﬁcult, standardization
of a multidisciplinary clinical pathway from prehospital transfer through
postoperative intensive care unit care is associated with improved patient out-
comes after open repair andEVARof rAAAs, suggesting there is beneﬁt beyond
the “EVAR-ﬁrst protocol” to a standardized multidisciplinary pathway.
Midterm Outcomes After Prearteriotomy Guidewire Access (PAGA)
With Antegrade Recanalization in Patients With Extensive
Aortoiliofemoral Occlusive Disease Without the Use of a Re-entry
Device
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Houston, Tex
Objectives: A prearteriotomy guidewire access (PAGA) was described
to treat bulky iliofemoral occlusive disease. A wire is passed ﬁrst from the
groin into the aorta, before the arteriotomy, to increase technical success.
Achieving retrograde intraluminal access in extensive aortoiliofemoral occlu-
sive disease (AIFOD) can be a challenge. We modiﬁed the PAGA technique
to successfully recanalize extensive aortoiliofemoral occlusion performed
with adjunctive femoral artery reconstruction as an alternative to extra-
anatomic bypass in high-risk patients for aortobifemoral bypass.
Methods: We approach these cases via a left brachial approach and
groin cutdown. Once brachial access is obtained, the patient is systematically
heparinized. Then, a 90-cm destination sheath is placed in the distal aorta. A
stiff glidewire and a guide catheter are used to recanalize the chronic
AIFOD. The wire is passed in an antegrade fashion across the AIFOD all
the way toward the femoral head. A femoral arteriotomy is done to capture
the wire, thus establishing access from the groin into the patent aorta.External iliac artery and femoral artery endarterectomy is performed around
the wire. The wire is passed through the patch before the patch angioplasty
is completed. Once femoral revascularization is done, a sheath is placed over
the wire, and retrograde iliac stenting is performed to the level above the
patch to avoid crossing the inguinal ligament.
Results: This procedure has been performed in 18 patients (13 with
critical limb ischemia, 5 with claudication) with 94.4% technical success,
without the use of a re-entry device. Four patients required an interposition
graft, and 14 (77.8%) required femoral endarterectomy with patch angio-
plasty. The procedures in 10 patients (55.5%) were done under spinal anes-
thesia. All patients had signiﬁcant cardiopulmonary comorbidities, and ﬁve
had had multiple abdominal surgeries. One patient (5.5%) required oral an-
tibiotics to treat a superﬁcial wound infection. One patient (5.5%) died #30
days (massive myocardial infarction), and one patient required an axillobife-
moral bypass at 6 months for acute stent occlusion. The remaining 17 pa-
tients were symptom free, with patent stents, at a mean of 16.5 months
(range, 12-22 months).
Conclusions: Modiﬁed PAGA can be used to safely revascularize
high-risk patients with extensive AIFOD, with acceptable complication
rate and patency. This procedure is currently offered to patients with aortoi-
liofemoral disease, not candidates for aortobifemoral bypass, instead of an
extra-anatomic bypass.
Robotic Vascular Surgery
Petr Stadler, MD, PhD. Na Homolce Hospital, Praha 5, Czech Republic
Objectives: The feasibility of laparoscopic aortic surgery has been
adequately demonstrated. Our clinical experience with robot-assisted aor-
toiliac reconstruction for occlusive diseases, aneurysms, endoleak type II
treatment, and hybrid procedures performed using the da Vinci system is
described.
Methods: Between November 2005 and August 2013, we performed
290 robot-assisted vascular procedures. A total of 212 patients were pro-
spectively evaluated for occlusive diseases, 57 patients for abdominal aortic
aneurysm, 4 for a common iliac artery aneurysm, 3 for a splenic artery aneu-
rysm, 1 for an internal mammary artery aneurysm, 5 for hybrid procedures,
and 8 for endoleak type II treatment after endovascular aneurysm repair.
The robotic system was applied to construct the vascular anastomosis, for
the thromboendarterectomy, for the aortoiliac reconstruction with a closure
patch, for dissection of the splenic artery, and for the posterior peritoneal
suture. A combination of conventional laparoscopic and robotic surgeries
were initially included. A modiﬁed, fully robotic approach, without laparo-
scopic surgery, was used in the last 120 cases in our series.
Results: A total of 279 cases (96%) were successfully completed
robotically. One patient’s surgery was discontinued during laparoscopy
due to heavy aortic calciﬁcation. In 10 patients (3.4%), conversion was
necessary. The 30-day mortality rate was 0.3%, and early nonlethal postop-
erative complications were observed in six patients (2%).
Conclusions: Our experience with robot-assisted laparoscopic sur-
gery has demonstrated the feasibility of this technique for occlusive diseases,
aneurysms, endoleak type II treatment after endovascular aneurysm repair,
and hybrid procedures. The da Vinci robotic system facilitated the creation
of the aortic anastomosis, and shortened the aortic clamping time compared
with purely laparoscopic techniques.
Fig. The central anastomosis of AAA.
